skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Thymidine analogues to assess microperfusion in human tumors

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [2];  [1];  [2];  [2];  [3];  [1]
  1. Division of Experimental Therapy, Netherlands Cancer Institute, Amsterdam (Netherlands)
  2. Department of Radiation Oncology, University Medical Center Nijmegen, Nijmegen (Netherlands)
  3. Department of Radiation Oncology, University Hospital Gasthuisberg, Leuven (Belgium)

Purpose: To validate the use of the thymidine analogues as local perfusion markers in human tumors (no labeling indicates no perfusion) by comparison with the well-characterized perfusion marker Hoechst 33342. Methods and Materials: Human tumor xenografts from gliomas and head-and-neck cancers were injected with iododeoxyuridine (IdUrd) or bromodeoxyuridine (BrdUrd) and the fluorescent dye Hoechst 33342. In frozen sections, each blood vessel was scored for the presence of IdUrd/BrdUrd labeling and Hoechst in surrounding cells. The percentage of analogue-negative vessels was compared with the fraction of Hoechst-negative vessels. Collocalization of the two markers was also scored. Results: We found considerable intertumor variation in the fraction of perfused vessels, measured by analogue labeling, both in the human tumor xenografts and in a series of tumor biopsies from head-and-neck cancer patients. There was a significant correlation between the Hoechst-negative and IdUrd/BrdUrd-negative vessels in the xenografts (r 85, p = 0.0004), despite some mismatches on a per-vessel basis. Conclusions: Thymidine analogues can be successfully used to rank tumors according to their fraction of perfused vessels. Whether this fraction correlates with the extent of acute hypoxia needs further confirmation.

OSTI ID:
20698628
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 62, Issue 4; Other Information: DOI: 10.1016/j.ijrobp.2005.03.063; PII: S0360-3016(05)00601-2; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo
Journal Article · Sat Apr 30 00:00:00 EDT 1994 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:20698628

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O{sub 2} consumption?
Journal Article · Fri Jul 15 00:00:00 EDT 2016 · Medical Physics · OSTI ID:20698628

Irradiation-Dependent Effects on Tumor Perfusion and Endogenous and Exogenous Hypoxia Markers in an A549 Xenograft Model
Journal Article · Sun Aug 01 00:00:00 EDT 2010 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20698628